OSE Immunotherapeutics SA
EPA:OSE.PA
7.5 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -23.003 | -17.76 | -16.85 | -16.555 | -4.652 | 5.49 | -10.503 | 20.666 | -5.584 | -2.835 | -0.25 | -1.436 |
| Depreciation & Amortization
| 3.471 | 3.557 | 2.606 | 0.73 | 0.482 | 0.116 | 0.123 | 0.107 | 0.099 | 0 | 0 | 0 |
| Deferred Income Tax
| -0.223 | -0.264 | -0.366 | -2.744 | 3.063 | -0.871 | -2.238 | -1.05 | -0.832 | 0 | 0 | 0 |
| Stock Based Compensation
| 2.034 | 3.13 | 3.773 | 2.283 | 1.868 | 0.845 | 1.373 | 0.68 | 1.857 | 0.135 | 0.006 | 0 |
| Change In Working Capital
| -0.835 | -3.142 | 1.025 | -2.92 | 8.555 | -4.59 | 3.249 | 0.37 | -1.025 | 0.763 | 0.009 | 0.047 |
| Accounts Receivables
| 0.578 | -0.369 | -0.302 | -0.377 | 1.506 | 2.126 | -12.191 | 0 | 0 | 0 | 0 | 0.048 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.759 | -1.067 | -0.679 | -3.368 | 0.363 | -2.221 | -4.521 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -2.172 | -1.706 | 2.006 | 0.825 | 6.686 | -4.495 | 19.961 | 0.37 | -1.025 | 0.763 | 0.009 | -0.001 |
| Other Non Cash Items
| 6.431 | -3.371 | -0.107 | -0.344 | -0.345 | -0.045 | -0.132 | -21.139 | 0.039 | 0 | -0.001 | -0.004 |
| Operating Cash Flow
| -19.764 | -18.252 | -9.919 | -19.55 | 8.971 | 1.077 | -7.996 | 0.684 | -4.614 | -1.937 | -0.236 | -1.393 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.232 | -0.274 | -0.472 | -0.21 | -0.336 | -0.593 | -0.353 | -0.03 | -0.043 | -0.025 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.304 | 0 | 0 | 0 | 0.531 |
| Purchases Of Investments
| -0.275 | 0 | 0 | 0 | 0 | 0 | -0.012 | -0.089 | -6.167 | 0 | 0 | -0.022 |
| Sales Maturities Of Investments
| 0 | 0.3 | 0 | 0 | 2.895 | 0.062 | 0 | 2.92 | 0 | 0 | 0 | 0.019 |
| Other Investing Activites
| -0.491 | 0.3 | -0.355 | -0.294 | -0.184 | -0.027 | 0.066 | 3.163 | 0.253 | 0 | 0 | -0.001 |
| Investing Cash Flow
| -0.507 | 0.026 | -0.827 | -0.504 | 2.375 | -0.558 | -0.299 | 6.105 | -5.957 | -0.025 | 0.185 | 0.527 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -2.304 | -11.046 | -15.241 | -6.635 | -5.174 | -0.485 | -0.465 | -0.821 | -0.345 | 0 | -0.33 | -0.028 |
| Common Stock Issued
| 11.657 | 0.006 | 0.265 | 17.427 | 0 | 0.03 | 0.035 | 0.155 | 18.047 | 2.778 | 0.001 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -0.067 | -0.067 | -0.098 | -0.279 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -5.438 | 21.307 | 29.933 | 12.788 | 10.097 | -0.07 | 3.553 | -0.47 | 1.381 | 2.778 | 0.317 | 0.83 |
| Financing Cash Flow
| 13.324 | 10.267 | 14.957 | 23.58 | 4.923 | -0.592 | 3.056 | -1.234 | 18.804 | 2.778 | 0.318 | 0.802 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.001 | 0 | 0 | 0 | 5.095 | 0 | 0 | 0 | 0.001 | 0 | 0.013 | -0.001 |
| Net Change In Cash
| -6.948 | -7.959 | 4.211 | 3.526 | 21.364 | -0.073 | -5.239 | 5.555 | 8.234 | 0.816 | 0.095 | -0.064 |
| Cash At End Of Period
| 18.672 | 25.62 | 33.579 | 29.368 | 25.842 | 9.573 | 9.646 | 14.885 | 9.33 | 1.096 | 0.28 | 0.185 |